Hsbc Holdings PLC Sarepta Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 158,639 shares of SRPT stock, worth $18.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

158,639

Previous 2,358 6627.69%

Holding current value

$18.9 Million

Previous $372,000 5226.34%

% of portfolio

0.01%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $19.4 Million - $24.5 Million	156,281 Added 6627.69%	158,639 $19.8 Million
Q2 2024 Aug 12, 2024	SELL	$113.33 - $163.85 $5.38 Million - $7.78 Million	-47,489 Reduced 95.27%	2,358 $372,000
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $2 Million - $3.02 Million	21,334 Added 74.82%	49,847 $6.45 Million
Q4 2023 Feb 12, 2024	BUY	$67.31 - $124.76 $1.75 Million - $3.24 Million	25,998 Added 1033.72%	28,513 $2.75 Million
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $53,197 - $64,143	519 Added 26.0%	2,515 $304,000
Q2 2023 Aug 11, 2023	SELL	$106.4 - $157.19 $1.79 Million - $2.64 Million	-16,780 Reduced 89.37%	1,996 $228,000
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $510,197 - $677,152	4,341 Added 30.07%	18,776 $2.59 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $1.46 Million - $1.91 Million	14,435 New	14,435 $1.87 Million
Q2 2022 Aug 11, 2022	BUY	$62.69 - $88.44 $4.4 Million - $6.2 Million	70,140 Added 1581.15%	74,576 $5.7 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $28,417 - $40,689	-450 Reduced 9.21%	4,436 $351,000
Q4 2021 Feb 11, 2022	BUY	$77.28 - $99.42 $377,590 - $485,766	4,886 New	4,886 $439,000
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $402,746 - $564,590	-6,105 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $1.09 Million - $1.36 Million	-15,660 Reduced 71.95%	6,105 $474,000
Q1 2021 May 14, 2021	BUY	$72.25 - $168.95 $632,476 - $1.48 Million	8,754 Added 67.28%	21,765 $1.62 Million
Q4 2020 Feb 25, 2021	BUY	$125.56 - $178.74 $572,553 - $815,054	4,560 Added 53.96%	13,011 $2.22 Million
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $283,640 - $403,773	-2,259 Reduced 21.09%	8,451 $1.44 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $1.07 Million - $1.45 Million	8,387 Added 361.04%	10,710 $1.52 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $394,599 - $728,523	-4,243 Reduced 64.62%	2,323 $372,000
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $540,907 - $864,348	6,566 New	6,566 $643,000
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $260,077 - $560,482	-3,572 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$112.21 - $151.95 $82,362 - $111,531	-734 Reduced 17.05%	3,572 $543,000
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $459,321 - $653,134	4,306 New	4,306 $513,000
Q2 2018 Aug 10, 2018	SELL	$71.74 - $153.69 $223,111 - $477,975	-3,110 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$54.02 - $82.27 $29,927 - $45,577	-554 Reduced 15.12%	3,110 $230,000
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $174,552 - $207,932	3,664	3,664 $203,000

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Sarepta Therapeutics, Inc. Transaction History